Article info
PDFEditors’ commentary
Highlights from this issue
Citation
Highlights from this issue
Publication history
- Accepted June 22, 2021
- First published July 23, 2021.
Online issue publication
January 10, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
- Marked olfactory impairment in idiopathic intracranial hypertension
- Optical coherence tomography imaging of the optic nerve head pre optic and post optic nerve sheath fenestration
- Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients
- Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre
- Severe papilloedema with vision loss secondary to Guillain-Barré syndrome
- Benefit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome
- Clinical review of retinotopy
- Visual hallucinations and sight loss in children and young adults: a retrospective case series of Charles Bonnet syndrome
- Guiding follow-up of paediatric idiopathic intracranial hypertension with optical coherence tomography